Jiqun Cai

Dr. Jiqun Cai


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2015 in Xenobiotica
Verified
Journal Article
Closed access
PDF file
XSXianbao Shi
Xianbao Shi
SYshuman yang
shuman yang
GZGang Zhang
Gang Zhang
YSYonggui Song
Yonggui Song
DSDan Su
Dan Su
JCJiqun Cai
Jiqun Cai
1. The aim of this study was to investigate the inhibitory effect of morusin on Glucuronosyltransferase (UGT) isoforms and cytochrome P450 enzymes (CYP450s). We also investigated the metabolism of morusin in human, rat, dog, monkey, and minipig liver microsomes. 2. 100 μM of morusin exhibited strong inhibition on all UGTs and CYP450s. The half inhibition concentration (IC50) values for CYP3A4, CYP1A2, CYP2C9, CYP2E1, UGT1A6, UGT1A7, and UGT1A8 were 2.13, 1.27, 3.18, 9.28, 4.23, 0.98, and 3.00 μM, and the inhibition kinetic parameters (Ki) were 1.34, 1.16, 2.98, 6.23, 4.09, 0.62, and 2.11 μM, respectively. 3. Metabolism of morusin exhibited significant species differences. The quantities of M1 from minipig, monkey, dog, and rat were 7.8, 11.9, 2.0, and 6.3-fold of human levels. The Km values in HLMs, RLMs, MLMs, DLMs, and PLMs were 7.84, 22.77, 14.32, 9.13, and 22.83 μM, and Vmax for these species were 0.09, 1.23, 1.43, 0.15, and 0.75 nmol/min/mg, respectively. CLint (intrinsic clearance) values (Vmax/Km) for morusin obeyed the following order: monkey > rat > minipig > dog > human. CLH (hepatic clearance) values for humans, dogs, and rats were calculated to be 8.28, 17.38, and 35.12 mL/min/kg body weight, respectively. 4. This study provided vital information to understand the inhibitory potential and metabolic behavior of morusin among various species.

15 April 2015 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Open access
PDF file
FGFeng Guo
Feng Guo
PZPei-Dong Zhou
Pei-Dong Zhou
QGQinghua Gao
Qinghua Gao
JGJian Gong
Jian Gong
RFRui Feng
Rui Feng
LHliying hao
liying hao
Culture of hippocampal neurons in low-Mg2+ medium (low-Mg2+ neurons) results in induction of continuous seizure activity. However, the underlying mechanism of the contribution of low Mg2+ to hyperexcitability of neurons has not been clarified. Our data, obtained using the patch-clamp technique, show that voltage-gated Na+ channel (VGSC) activity, which is associated with a persistent, noninactivating Na+ current ( INa,P), was modulated by calmodulin (CaM) in a concentration-dependent manner in normal and low-Mg2+ neurons, but the channel activity was more sensitive to Ca2+/CaM regulation in low-Mg2+ than normal neurons. The increased sensitivity of VGSCs in low-Mg2+ neurons was partially retained when CaM12 and CaM34, CaM mutants with disabled binding sites in the N or C lobe, were used but was diminished when CaM1234, a CaM mutant in which all four Ca2+ sites are disabled, was used, indicating that functional Ca2+-binding sites from either lobe of CaM are required for modulation of VGSCs in low-Mg2+ neurons. Furthermore, the number of neurons exhibiting colocalization of CaM with the VGSC subtypes NaV1.1, NaV1.2, and NaV1.3 was significantly higher in low- Mg2+ than normal neurons, as shown by immunofluorescence. Our main finding is that low-Mg2+ treatment increases sensitivity of VGSCs to Ca2+/CaM-mediated regulation. Our data reveal that CaM, as a core regulating factor, connects the functional roles of the three main intracellular ions, Na+, Ca2+, and Mg2+, by modulating VGSCs and provides a possible explanation for the seizure discharge observed in low-Mg2+ neurons.

1 January 2016 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
ZMZhongnv Ma
Zhongnv Ma
XSXianbao Shi
Xianbao Shi
GZGang Zhang
Gang Zhang
FGFeng Guo
Feng Guo
LSLina Shan
Lina Shan
JCJiqun Cai
Jiqun Cai
Cytochrome p450 (CYP450) enzymes are predominantly involved in Phase I metabolism of xenobiotics. In this study, the CYP450 isoforms involved in xanthotoxol metabolism were identified using recombinant CYP450s. In addition, the inhibitory effects of xanthotoxol on eight CYP450 isoforms and its pharmacokinetic parameters were determined using human liver microsomes. CYP1A2, one of CYP450s, played a key role in the metabolism of xanthotoxol compared to other CYP450s. Xanthotoxol showed stronger inhibition on CYP3A4 and CYP1A2 compared to other isoenzymes with the IC50 of 7.43 μM for CYP3A4 and 27.82 μM for CYP1A2. The values of inhibition kinetic parameters (Ki) were 21.15 μM and 2.22 μM for CYP1A2 and CYP3A4, respectively. The metabolism of xanthotoxol obeyed the typical monophasic Michaelis‐Menten kinetics and Vmax, Km, and CLint values were calculated as 0.55 nmol·min−1·mg−1, 8.46 μM, and 0.06 mL·min−1·mg−1. In addition, the results of molecular docking showed that xanthotoxol was bound to CYP1A2 with hydrophobic and π‐π bond and CYP3A4 with hydrogen and hydrophobic bond. We predicted the hepatic clearance (CLH) and the CLH value was 15.91 mL·min−1·kg−1 body weight. These data were significant for the application of xanthotoxol and xanthotoxol‐containing herbs.